Recruiting
Phase 2

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT00501826

Conditions

T Acute Lymphoblastic Leukemia

T Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Cytarabine

Dexamethasone

Doxorubicin Hydrochloride

Mercaptopurine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information